发明名称 ErbB-2 receptor targeting peptide
摘要 The ErbB-2 receptor, a member of the tyrosine kinase type 1 family of receptors, has been implicated in many human malignancies. Bacteriophage display technology was employed to identify peptides that bound to the extracellular domain of human ErbB-2. The peptide KCCYSL, most frequently occurring in the affinity selected population, was chemically synthesized and characterized for its binding activities to the recombinant extracellular domain of ErbB-2. The synthetic peptide exhibits high specificity to ErbB-2 as well as to ErbB-1, another member of ErbB family. Thus, this peptide can be employed in cancer imaging or therapeutic agent targeting to malignant cells ErbB-2 receptor.
申请公布号 US9061054(B2) 申请公布日期 2015.06.23
申请号 US200912555375 申请日期 2009.09.08
申请人 The Curators of The University of Missouri 发明人 Quinn Thomas P.;Karasseva Natalia G.
分类号 A61K49/00;G01N33/574;G01N33/74;A61K49/10;A61K33/24;A61B5/00;A61K51/08;A61K38/08 主分类号 A61K49/00
代理机构 Norton Rose Fulbright US LLP 代理人 Norton Rose Fulbright US LLP
主权项 1. A method for diagnosing ErbB-2-positive cancer in a subject comprising: (a) administering to said subject a peptide-diagnostic agent complex, wherein said peptide is between 6 and about 100 residues in length and comprises the sequence KCCYSL (SEQ ID NO: 1) and wherein the peptide binds to ErbB-2; and (b) assessing the amount and/or localization in said subject, of the diagnostic agent.
地址 Columbia MO US